Today: 12 May 2026
Beazley profit slides 19% as Zurich takeover advances and board adds PwC veteran Roy Clark
5 March 2026
1 min read

Beazley profit slides 19% as Zurich takeover advances and board adds PwC veteran Roy Clark

LONDON, March 5, 2026, 09:00 GMT

Beazley Plc on Wednesday posted a 19% drop in annual pre-tax profit, pressured by weaker insurance pricing and sluggish expansion in its cyber segment, just as a Zurich Insurance takeover looms. The company noted its Middle East conflict exposure remains limited and doesn’t anticipate any material effect.

Zurich has struck a deal to buy the London-listed specialty insurer for roughly £8.1 billion ($10.8 billion), a move that would expand the Swiss company’s reach in lines like cyber, marine, and aviation. “Together with Beazley, we will create the world’s leading Specialty underwriter,” said Zurich CEO Mario Greco. Jefferies noted the deal signals “Beazley’s loss exposures … remain contained.” Reuters

Shares of Beazley hovered near 1,289 pence in early London hours Thursday, Investing.com data showed. Investors remain alert to signs of a softer pricing cycle taking hold ahead of the deal’s close.

Beazley posted a pre-tax profit of $1,146.5 million for 2025, down from $1,423.5 million the previous year. Insurance written premiums edged down 1% to $6,100.7 million. The combined ratio moved up to 81% from 79%. Average renewal rates slipped 3.6%. Cyber underwriting was off 8.8% as the company kept a hard line on rates and terms in the U.S. “We delivered another strong profit … underwriting discipline and active cycle management continued to ensure our success,” CEO Adrian Cox said. Investegate

Beazley is holding its interim dividend steady at 25 pence per share, according to a filing. Shares go ex-dividend March 19, with payment scheduled for May 1. This is the “Permitted Dividend” mentioned in the takeover terms. Investegate

Zurich pulled in 3.9 billion Swiss francs ($5 billion) via a share placement this week to back its Beazley deal, unloading 7.1 million new shares at 550 francs apiece. The insurer said it would finance the remainder with a mix of existing cash and fresh debt lines. Zurich shares dropped 5.4% following the financing news.

Beazley shareholders will receive 1,310 pence in cash along with a 25 pence dividend, bringing the total payout to 1,335 pence per share under the deal. Completion is targeted for the second half of 2026 via a UK scheme of arrangement, the court-sanctioned takeover procedure.

Beazley has tapped Roy Clark—a longtime PwC executive—for a seat on its board as independent non-executive director. The move takes effect after regulatory approval of his chairmanship of the main underwriting arm, or post-2026 AGM, whichever is the later. “My Board colleagues and I are delighted to welcome Roy to the Board,” Chair Clive Bannister said. Investegate

Still, the deal isn’t past the standard regulatory hurdles yet. Specialty insurers like Beazley have profits that can whipsaw with major hits — cyber incidents, natural disasters, geopolitical flare-ups. If pricing drops more than expected, Beazley’s track record, plus the earnings Zurich is counting on, could come under pressure.

Beazley’s investor calendar shows the annual general meeting set for April 22, with a first-quarter trading update due out April 30.

Stock Market Today

  • HSIC Posts Robust Q1 2026 Sales and Margin Gains Driven by U.S. Dental, Technology Units
    May 12, 2026, 12:09 PM EDT. Henry Schein Inc. (HSIC) delivered strong sales and margin growth in the first quarter of 2026. The U.S. Dental segment led the rise, supported by solid performance in technology divisions. These gains highlight continued demand in healthcare supply and technology services, underpinning HSIC's solid market position. Investors will watch upcoming earnings for further details on segment contributions and outlook amid evolving healthcare needs.

Latest article

Hims & Hers’ GLP-1 Reset Hits the Stock as Investors Reprice Growth Quality

Hims & Hers’ GLP-1 Reset Hits the Stock as Investors Reprice Growth Quality

12 May 2026
Hims & Hers Health shares fell 14.6% to $24.89 Tuesday after a Q1 net loss of $92.1 million, reversing a $49.5 million profit a year ago. Revenue rose 4% to $608.1 million, but gross margin dropped to 65% from 73% as the company shifted from compounded GLP-1s to branded drugs like Wegovy and Ozempic. Subscribers climbed to 2.584 million, while monthly revenue per subscriber slipped to $80.
POET Stock Rebounds as New COO Gives AI-Photonics Rally a Fresh Test

POET Stock Rebounds as New COO Gives AI-Photonics Rally a Fresh Test

12 May 2026
POET Technologies named Sandeep Kumar as chief operating officer, triggering a 2.95% stock rise to $14.31 on heavy volume after shares hit $15.15 intraday. Kumar, formerly of Silicon Labs, will oversee Malaysia manufacturing as the company targets high-volume production. The move comes after Marvell canceled Celestial AI orders, which had weighed on the stock. Broader tech indices fell Tuesday, but POET shares outperformed.
IREN Stock Slips as Nvidia Deal Runs Into the Price of Building AI Capacity

IREN Stock Slips as Nvidia Deal Runs Into the Price of Building AI Capacity

12 May 2026
IREN shares fell about 2.4% to $53.80 Tuesday after the company priced an upsized $2.6 billion convertible-note sale, raising concerns over funding costs and dilution. The notes carry a 1% coupon and can convert at $73.07 per share. IREN reported a $247.8 million net loss last quarter. Peers Cipher Digital, Riot Platforms, and Marathon Digital also traded lower.

Popular

Xero Limited’s new data show U.S. small-business sales cooled as Canada slips to pandemic-era levels
Previous Story

Xero Limited’s new data show U.S. small-business sales cooled as Canada slips to pandemic-era levels

BW stock jumps after Babcock & Wilcox gets $2.4 billion green light to build AI data-center power project
Next Story

BW stock jumps after Babcock & Wilcox gets $2.4 billion green light to build AI data-center power project

Go toTop